Ovarian Cancer Canada

Western Regional Blog – BC, YK, AB, NWT and Nunavut

Prevention of Palmar–Plantar Erythrodysesthesia in Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin

TAKE-HOME MESSAGE Given the observation that elevated concentrations of doxorubicin are found in eccrine sweat glands

April 22, 2014

EMA recommends approval of new treatment for platinum-resistant ovarian cancer together with companion diagnostic

Vynfinit gains European approval for treatment of platinum-resistant ovarian cancer.

April 22, 2014

Study discovers genetic cause of rare type of ovarian cancer

Causative mutation found for rare form of ovarian cancer affecting young women A rare type of ovarian cancer called small cell carcinoma of the ovary, hypercalcemic type (or SCCOHT)

April 22, 2014

Bisphosphonates Reduce Risk of Gynecologic Cancers

TAKE-HOME MESSAGE This case-control study of postmenopausal women demonstrated that bisphosphonate use for 1 year or more decreased the risk of developing

April 22, 2014

Bevacizumab Plus Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer

TAKE-HOME MESSAGE  This randomized trial enrolled 361 platinum-resistant ovarian cancer patients who received single-agent chemotherapy

April 22, 2014

Cancer and Returning to Work: A Practical Guide for Cancer Patients

Second Edition, Created by Maureen Parkinson, M.Ed, CCRC, Vocational Rehabilitation Counsellor, Psychosocial Oncology Program, BC Cancer Agency

April 17, 2014

Resources: Treatment for Endometrial Cancer, Uterine Sarcoma

Endometrial Cancer Treatment (PDQ): Treatment Options by Stage  Source: National Cancer Institute   Uterine Sarcoma Treatment (PDQ): Treatment Options by Stage  Source: National Cancer Institute

April 1, 2014

CDC’s Cervical Cancer Study (US Centers for Disease Control)

Source: National Cancer Institute http://www.cdc.gov/cancer/dcpc/research/articles/cervical-cancer-study.htm  Cervical cancer is most often caused by a genital human papillomavirus (HPV) infection. HPV infection is common and often goes away on its own. Persistent … Continue reading

April 1, 2014

Bevacizumab Improves Survival in Cervical Cancer

Abstract: N Engl J Med. 2014;370(8):734-743.  Results of the Gynecologic Oncology Group (GOG) Trial 240 showed that the addition of bevacizumab to combination chemotherapy in patients with recurrent, persistent, or … Continue reading

April 1, 2014

Complementary and Alternative Therapies

CAMEO

Research in BC

The Injustices of Ovarian Cancer

Ovarian Cancer Canada